Whats new here is the consistency across tumor types, and data this large and this consistent warrant a prospective randomized trial. Glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide (Ozempic or Wegovy), were originally developed to treat diabetes and were later approved for obesity
Open communication with your diabetes care team ensures that any concerns are addressed promptly and that your treatment plan remains safe and effective
Some plans cover semaglutide for both diabetes and weight management, while others exclude weight-loss medications entirely
In the STEP 1 extension, participants regained about two-thirds of lost weight within a year off-drug (net 5.6% vs
Our partnership with Abbott will help make this innovative molecule accessible to a greater number of people living with type 2 diabetes in India, Vikrant Shrotriya, Managing Director, Novo Nordisk India, said
To perform the proper treatment, we must first correctly diagnose the cause